In the last trading session, 3.05 million shares of the X4 Pharmaceuticals Inc (NASDAQ:XFOR) were traded, and its beta was 0.49. Most recently the company’s share price was $1.26, and it changed around $0.06 or 5.00% from the last close, which brings the market valuation of the company to $211.60M. XFOR currently trades at a discount to its 52-week high of $2.58, offering almost -104.76% off that amount. The share price’s 52-week low was $0.57, which indicates that the current value has risen by an impressive 54.76% since then. We note from X4 Pharmaceuticals Inc’s average daily trading volume that its 3-month average coming to 2.32 million.

X4 Pharmaceuticals Inc (NASDAQ:XFOR) trade information

Instantly XFOR has showed a green trend with a performance of 5.00% at the end of last trading. The performance over the last five days has remained in the red territory. The company’s shares are currently up 50.27% year-to-date, but still down -5.97% over the last five days. On the other hand, X4 Pharmaceuticals Inc (NASDAQ:XFOR) is 23.53% up in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $3.67, which translates to bulls needing to increase their stock price by 65.67% from its current value. Analyst projections state that XFOR is forecast to be at a low of $3 and a high of $5.

X4 Pharmaceuticals Inc (XFOR) estimates and forecasts

X4 Pharmaceuticals Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 48.24 percent over the past six months and at a 17.54% annual growth rate that is well above the industry average of 13.30%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 73.95%.

XFOR Dividends

X4 Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in May.